Reduced levels of XIAP, rather than other IAPs, is necessary for developmental apoptosis to proceed, and its upregulation has been found to be associated with chemotherapy resistance and unfavorable outcome in relapsed and advanced stage neuroblastoma (10, 11). The gene discussed is XIAP; the disease is neuroblastoma.